RecruitingNCT05626296

Molecular Network Characteristics of Phlegm-heat Syndrome in Ischemic Stroke Based on Multi-omics Integrated Analysis


Sponsor

Dongzhimen Hospital, Beijing

Enrollment

24 participants

Start Date

Nov 14, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The molecular characteristics of ischemic stroke with phlegm-heat syndrome and candidate biomarkers were identified based on multi-omics data. The main purpose of this study is to validate the molecular characteristics and biomarkers of phlegm-heat syndrome in ischemic stroke, and to demonstrate the association of biomarkers with clinical outcomes.


Eligibility

Min Age: 50 YearsMax Age: 80 Years

Inclusion Criteria5

  • Acute ischemic stroke, were confirmed by magnetic resonance imaging (MRI).
  • Symptom onset within 72 hours.
  • Diagnosis of phlegm-heat syndrome or non-phlegm-heat syndrome.
  • Male or female ≥ 50 years and ≤ 80 years.
  • With written informed consent.

Exclusion Criteria5

  • Planned or already receiving intravenous thrombolysis or endovascular treatment.
  • Acute infectious diseases or acute exacerbations of chronic diseases within one month before enrollment.
  • Patients with previous stroke.
  • Renal or hepatic insufficiency, tumors, immune diseases, severe underlying diseases.
  • Other conditions that may affect the collection and evaluation of clinical information (e.g., severe aphasia, mental illness).

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Dongzhimen Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05626296


Related Trials